Artesunate versus quinine for severe falciparum malaria

Author(s): Woodrow CJ, Planche T, Krishna S

Abstract

Background: In the treatment of severe malaria, intravenous artesunate is more rapidly acting than intravenous quinine in terms of parasite clearance, is safer, and is simpler to administer, but whether it can reduce mortality is uncertain.

Methods: We did an open-label randomised controlled trial in patients admitted to hospital with severe falciparum malaria in Bangladesh, India, Indonesia, and Myanmar. We assigned individuals intravenous artesunate 2.4 mg/kg bodyweight given as a bolus (n=730) at 0, 12, and 24 h, and then daily, or intravenous quinine (20 mg salt per kg loading dose infused over 4 h then 10 mg/kg infused over 2-8 h three times a day; n=731). Oral medication was substituted when possible to complete treatment. Our primary endpoint was death from severe malaria, and analysis was by intention to treat.

Similar Articles

Medicinal plants in therapy

Author(s): Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z

Burger's medicinal chemistry and drug discovery

Author(s): James F, Kerwin Jr.

Antimalarial drug resistance

Author(s): White NJ

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

Author(s): Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group

Artemisinins: activities and actions

Author(s): Haynes RK, Krishna S

Artemisone--a highly active antimalarial drug of the artemisinin class

Author(s): Haynes RK, Fugmann B, Stetter J, Rieckmann K, Heilmann HD, et al.

A single amino acid residue can determine the sensitivity of SERCAs to artemisinins

Author(s): Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, et al.

Identification of an antimalarial synthetic trioxolane drug development candidate

Author(s): Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FC, et al.

Synthetic studies towards halichondrins: synthesis of the C

Author(s): Aicher TD, Buszek KR, Fang FG, Forsyth CJ, Jung SH, et al.

Enabling high-throughput discovery

Author(s): Vaschetto M, Weissbrod T, Bodle D, Güner O